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     INTRODUCTION 
  Human African trypanosomiasis, or sleeping sickness, is a 
parasitic disease caused by infection with   Trypanosoma bru-
cei rhodesiense   ( T. b. rhodesiense  ) or   T. b. gambiense . The  para-
sites are transmitted through the bite of the tsetse fly insect 
vector. Although the two infections are geographically and 
clinically distinct, both forms of the disease are invariably fatal 
if not diagnosed and treated effectively with the appropriate 
drugs.  1   T. b. gambiense  is found in West Africa, and the infection 
follows a chronic course that can last for several years before 
death ensues.   T. b. rhodesiense   is found in East Africa and fol-
lows a more acute pattern of infection lasting only weeks to 
months.  2   After infection, the disease progresses in two stages: 
the early or hemolymphatic stage, where the parasites prolifer-
ate in the blood, lymph, and peripheral tissues, and the late or 
encephalitic stage, where the trypanosomes invade and become 
established within the central nervous system (CNS).  2,  3   
 The pathological changes that occur during the CNS stage of 
the disease have been described in only a very limited number 
of samples. The inflammatory pattern is associated with the 
progressive development of a meningoencephalitis character-
ized by astrocyte and microglial cell activation with accom-
panying T-cell and monocyte transmigration into the brain. 
This reaction increases in severity as the disease advances, and 
plasma cells become a common feature within the inflamma-
tory lesions together with the occasional Mott or Morular cell. 
In some instances, the reaction can take the form of an acute 
hemorrhagic leukoencephalopathy. However, neuronal dam-
age and demyelination are minimal.  4–  7   This inflammatory pat-
tern has been mirrored in both rodent and primate models of 
the human disease.  8–  11  
  Despite our knowledge of the pathological substrates of 
the neuroinflammatory reaction, the mechanisms that facili-
tate trypanosome invasion of the CNS and the effects of this 
process on the blood–brain barrier (BBB) remain unclear.  1  
Histopathological studies in animal models to determine the 
condition of the BBB after infection have produced equivocal 
results. A study by Philip and others  12   showed that fluorescent 
dye, injected into the jugular vein, could penetrate the BBB 
and permeate the brain parenchyma of trypanosome-infected 
rats, and indicated a progressive loss of barrier integrity as the 
disease advanced. However, a second investigation in a rat 
model showed no loss of the tight junction proteins occludin 
or zona occludens-1 and could not detect significant albumin 
leakage into the brain after trypanosome infection.  13  This  sug-
gests that trypanosomes enter the brain by a mechanism that 
does not result in indiscriminate damage to the BBB. 
  In the case of human infections, there is a paucity of data 
regarding the changes that occur at the BBB after infection. 
This is largely because of the lack of neuroimaging facilities 
in the countries affected by the disease. There are, however, a 
few reports where magnetic resonance imaging (MRI) tech-
nology has been applied. Several studies report increases in 
signal intensity in the internal and external capsule, corpus 
callosum, basal ganglia, and cerebellum after gadolinium 
enhancement.  14–  17   Because contrast agents should not readily 
pass through the intact BBB, these findings suggest that the 
integrity of the barrier has been compromised in these indi-
viduals at the time of the scan. 
 MRI has several advantages over the conventional histologi-
cal approaches in studies investigating the BBB. The technique 
allows imaging of the whole brain and can indicate specific 
areas where changes in barrier integrity occur. Furthermore, 
because MRI is performed   in vivo  , any alterations to the BBB 
must be regarded as a consequence of the disease process 
and cannot be attributed to artefact as a result of the animal’s 
death. In this investigation, we have, for the first time, applied 
small-bore MRI in conjunction with the administration of a 
gadolinium-based contrast agent to visualize and quantify 
changes in the BBB integrity associated with the early CNS 
stage of the disease using a well-established murine model of 
human African trypanosomiasis. 
   MATERIALS AND  METHODS 
  Animals  and  infections.     Female CD-1 mice (Charles River 
Laboratories Inc., Margate, Kent, UK) were infected with 
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2 × 10  4    T. b. brucei   parasites of cloned stabilate GVR35 by 
intraperitoneal injection. In this model, the mice develop a 
fluctuating parasitemia, and the parasites become established 
within the CNS between 14 and 21 days post-infection. After 
this time point, the infection can no longer be cured using 
primary stage drugs. This indicates that the disease has entered 
the secondary or CNS stage of the infection. The severity of 
the neuropathological response in these mice increases in 
a stepwise manner as the infection progresses.  18   Without 
chemotherapeutic intervention, the animals survive for around 
35 days. For the purposes of this study, three animals were 
prepared for MRI on day 28 post-infection. An additional six 
mice were killed, and their brains were excised, fixed in 4% 
neutral buffered formalin, and paraffin wax-processed for 
histological analysis. Uninfected mice were also examined in 
an identical fashion to the infected animals. 
  All animal experiments were authorized in the United 
Kingdom under the Animals (Scientific Procedures) Act 1986 
and approved by the University of Glasgow Ethical Review 
Committee .
   MRI  measurements.     Mice were anaesthetized with 1–2% 
isofluorane (Baxter Healthcare, Newbury, Berkshire, UK) 
delivered in a mixture of 70:30 N  2 O:O 2 . To facilitate administration 
of contrast agent during the scanning protocol, a tail vein was 
cannulated with a 26-gauge × 19-mm cannula, and the animals 
were placed prone into a mouse cradle. To restrict movement, 
the head was restrained using ear and tooth bars, and the surface 
coil was placed above the head of the animal. Anesthesia was 
maintained throughout the procedures, and respiration and 
heart rate were observed. Body temperature was continuously 
monitored by a rectal thermocouple, and the animal was 
maintained normothermic by an enclosed warm-water circuit      . 
  MRI was performed on a Bruker Biospec 7T/30-cm system 
(Bruker, Ettlingen, Germany) equipped with an inserted gradi-
ent coil (121 mm ID, 400 mT/m) and a 72-mm birdcage resona-
tor. A surface coil was used for brain imaging. MRI was carried 
out on control (non-infected mice) and 28-day post-infection 
mice. The protocol consisted of a rapid acquisition with relax-
ation  enhancement  (RARE)    T 2  -weighted scan (effective echo 
time [TE] = 76 ms, repetition time [TR] = 5,362 ms, 25 aver-
ages, matrix = 176 × 176, field of view [FOV] = 17.6 × 17.6 
mm, 25 contiguous coronal slices of 0.4-mm thickness) fol-
lowed by a RARE T  1  -weighted scan (effective TE = 9 ms, TR 
= 8,000 ms, 20 averages, matrix = 176 × 176, FOV = 17.6 × 17.6 
mm, 25 contiguous coronal slices of 0.4-mm thickness). After 
this scan, 0.1 mL of a solution containing 50 μL gadolinium-
diethylenetriamine penta-acetic acid (Gd-DPTA; Magnevist, 
Bayer HealthCare, Uxbridge, Middlesex, UK) and 50 μL of 
sterile water were injected through the tail vein cannula, and 
the T  1  -weighted scan was repeated after a delay of 5 min after 
contrast agent injection. Gd-DTPA cannot readily cross the 
intact BBB because of its charge and high molecular weight.  19  
When injected intravenously, Gd-DTPA will accumulate in 
regions of damage and result in a local increase in the MRI 
signal intensity. Extravasation of Gd-DTPA observed within 
the parenchyma shows an impairment of the BBB integrity. 
  Image J software (  http://rsbweb.nih.gov/ij/  ) was used for 
image analysis. Contrast agent enhancement maps were gener-
ated from the signal of the pre- and post-contrast T  1 -weighted 
scans according to the following equation
 Enh   = (Spost − Spre)/Spre
where   S  post     is the post-contrast agent signal and   S  pre     is the pre-
contrast agent signal. 
  Regions of interest (ROIs) were manually defined to 
include the entire brain and meninges. The mean percentage 
signal change for each brain slice was then calculated. 
      Assessing the severity of the neuroinflammation.    Hema-
toxylin and eosin (H&E)-stained sections through the 
hippocampal brain region were examined by two independent 
assessors in a blinded fashion. The severity of the neurological 
reaction was graded using a previously described grading 
scale (  Table 1  ),  20   where 0 represents a normal brain, grade 1 
shows mild meningitis, grade 2 shows moderate meningitis 
with the development of some perivascular cuffs, grade 3 
shows more severe meningitis and perivascular cuffing with 
the presence of some inflammatory cells in the neuropil, and 
grade 4 is characterized by a severe meningoencephalitis with 
inflammatory cells throughout the parenchyma. 
       Statistical  analysis.     Statistical analyses of the neuro-
pathological response were performed. A Wilcoxon signed 
rank test was used to compare gradings from the two assessors 
for evidence of any significant difference. In addition, Fleiss’ 
κ statistic was calculated as a measure of agreement between 
assessors. Thereafter, a general linear model was performed 
on the mean grading scores of the two assessors to test for 
significant differences (5% level) between the two groups of 
mice and to obtain an estimate of the mean difference and its 
95% confidence interval. 
  Analysis of the post-contrast signal enhancement data from 
the MRI investigations was performed using a three-factor 
nested general linear model to test for a difference (5% level) 
between infected and uninfected animals and to estimate the 
size of the treatment effect and its 95% confidence interval. 
The design took account of mice being nested within treat-
ment groups, and both mouse and slice factors were consid-
ered to be random. 
    RESULTS 
  MRI.     The percentage signal change detected after injection 
of contrast agent in mice at 28 days post-infection (least 
 Table 1 
    Outline of the parameters used to define the neuropathological injury score allocated to grade the severity of the neuroinflammatory reaction 
encountered in the murine CNS after trypanosome infection  20   
Score
01 2 3 4
Meningitis None Mild Moderate Severe Severe
Perivascular cuffing None None Mild cuffing of 
some vessels
Prominent cuffing of 
some vessels
Prominent cuffing of 
most vessels
Encephalitis as defined by cellular 
activity in the neuropil
None None None Moderate Severe346 RODGERS AND OTHERS
squares mean = 26.709) was significantly higher (  P   = 0.028) 
than that seen in uninfected control animals (least squares 
mean = 6.298). This represented a mean increase of 20.41%, 
with a 95% confidence interval of 18.77–22.05. The difference 
between the levels of contrast agent reaching the brain in 
infected animals compared with their uninfected counterparts 
is apparent on examination of the percentage signal change 
maps shown in  Figure 1 , where images from infected mice show 
many areas of brighter coloration, indicating regions where 
contrast agent is present. In the infected animals, increased 
signal was identified in multiple brain regions, although the 
areas showing the highest level of signal change were found 
in the meninges and ventricular region (  Figures 1   and   2  ). The 
presence of meningeal enhancement in the infected mice can 
be clearly visualized in the post-contrast scan images shown 
in   Figure 2  . Areas of signal change were also present in the 
cortex and thalamus as well as circumventricular regions, 
including the hypothalamus, suprachiasmatic nucleus, and 
median eminence. In addition, several vessels showing high 
levels of contrast could be recognized penetrating the cortex. 
In comparison, uninfected control mice showed only very 
limited signal enhancement that was largely confined to the 
ventricular area or the occasional large vessel entering the 
brain (  Figure 1  ). 
     Neuropathological  response.     The median of the difference 
between the gradings of the assessors was 0, with a 95% 
confidence interval of 0–0.25, and this was not significant. The 
measure of agreement between assessors led to a κ value of 
0.812, which indicated almost perfect agreement. 
  The severity of the neuropathological reaction in uninfected 
mice and animals at 28 days after infection was examined to 
determine whether the areas of signal change detected by 
MRI corresponded with areas of more severe inflammation in 
the mice. Mice killed at day 28 post-infection during the early 
CNS stage of the disease exhibited minor neuroinflammatory 
changes, with a mean neuropathology score of 1.917 ± 0.167 
(mean ± standard error [SE]). This was characterized by the 
presence of a mild to moderate meningitis in these mice with 
inflammatory cells apparent in the meninges and the perivas-
cular space surrounding some blood vessels ( Figure 3B and D ). 
The perivascular cuffing was particularly prominent around 
the blood vessels of the hippocampal fissure (  Figure 3D  ). The 
inflammatory cell infiltrate was composed of macrophages, 
lymphocytes, and plasma cells. The neuropathological reaction 
found in mice exhibiting the early CNS stage of the disease 
was, as expected, significantly higher (  P   < 0.0001; 95% confi-
dence interval for the difference in mean score = 1.545–2.288) 
than that seen in normal uninfected animals where no neu-
roinflammatory changes were detected (  Figure 3A and C  ). 
     DISCUSSION 
  To date, the effects of trypanosome infection on the BBB 
have remained unclear. To our knowledge, this is the first 
report of the use of small-bore MRI to assess BBB breakdown 
in experimental trypanosomiasis infection. This study clearly 
shows that trypanosome infection compromises the integrity 
of the barrier when the mice exhibit pathological changes mir-
roring the early CNS stage of human disease. At this time, only 
mild to moderate inflammatory changes were detected on his-
tological examination of brain sections, with limited inflamma-
tory cell infiltration of the meninges and the perivascular space 
 Figure 1.        Percentage signal change map showing eight represen-
tative sections taken from a control uninfected mouse (Left) and a 
mouse scanned at 28 days after infection with   T. b. brucei   (Right). The 
color bar illustrates the percentage signal change, with brighter col-
ors indicating higher levels of change. The areas showing the brightest 
colors correspond to the regions with the highest BBB impairment. 
These are situated in the ventricular regions; however, widespread 
increases in signal change over those seen in the control mouse are 
apparent throughout the brain sections.       347 MRI OF BBB DAMAGE IN T. BRUCEI INFECTION
in some vessels. Trypanosomes were not visualized within the 
brain parenchyma in this study; however, previous investiga-
tions have shown numerous parasites in the interventricular 
foramen,  21   and Taqman polymerase chain reaction (PCR) 
confirms that a substantial number of parasites are present in 
the brain at this point in the infection (Rodgers       J and others, 
unpublished data). Under physiological conditions, the traffic 
of lymphocytes across the BBB is strictly controlled, with only 
 Figure 2.        MRI scans generated after administration of contrast agent in an uninfected mouse (  A   and   C  ) and an animal scanned 28 days after 
infection with   T. b. brucei   ( B   and   D  ). Arrowheads indicate the presence of clear meningeal enhancement in the infected mouse compared with the 
uninfected animal.   A   and   B   correspond with the hindmost section, whereas   C   and   D   correspond with the foremost section shown in   Figure 1  .       
 Figure 3.        Coronal sections through the brain of a normal mouse (  A   and   C  ) and a mouse killed at 28 days after   T. b. brucei   infection (  B   and   D ). 
Infiltrating inflammatory cells (arrowheads) can be seen in the meninges of the cerebral cortex (  B  ) and surrounding the blood vessels in the hip-
pocampal fissure (  D  ) in the infected animal, whereas no inflammatory infiltrate is apparent in comparative areas in the normal mouse (  A   and   C ) .    348 RODGERS AND OTHERS
a few activated cells transmigrating across the barrier.  22   In this 
case, it is interesting to note the apparent disparity between 
the diffuse distribution and degree of BBB leakage seen 
on MRI examination and the localized neuroinflammatory 
changes exhibited by mice at this stage in the infection. This 
suggests that, although BBB integrity has been compromised 
at this point in the development of the CNS inflammatory 
reaction, the brain, to a large extent, remains compartmen-
talized from the peripheral systems and maintains the tight 
regulatory process responsible for controlling inflammatory 
cell transmigration into the brain. A similar picture has been 
reported in multiple sclerosis (MS) and experimental autoim-
mune encephalomyelitis (EAE); lymphocyte recruitment into 
the CNS remains tightly managed under inflammatory condi-
tions, despite the presence of BBB impairment, because the 
T cells infiltrating the brain parenchyma have been shown 
to be phenotypically distinct from those present in other tis-
sues.  22   The development of leaky vessels, attributed to a loss 
of the tight junction protein claudin-3, that was not dependant 
on the presence of inflammatory cells has also been reported 
in glioblastoma multiforme.  23   It is possible that the disparity 
seen after trypanosome infection could indicate that the BBB 
impairment found in animals at this stage in the disease pro-
cess is not solely the result of damage caused by the ongoing 
inflammatory process present within the CNS compartment 
and may be a direct consequence of the presence of the par-
asite. Indeed,   T. b. rhodesiense   parasites have been shown to 
cross   in vitro   BBB systems using cultures of human brain 
microvascular endothelial cells through a paracellular route, 
with only a transient reduction in the transendothelial elec-
trical resistance and causing no permanent damage to bar-
rier integrity.  24   Furthermore, it seems that parasite-derived 
cysteine protease enzymes are important factors enabling this 
traversal of the barrier.  25  
  In MS, MRI has shown the presence of lowered BBB integ-
rity preceding the development of clinical symptoms of the 
disease, and this was associated with a substantial infiltration 
of T cells and the presence of demyelinative lesions.  26,  27   Recent 
investigations have provided additional insight into the devel-
opment of these inflammatory lesions in EAE, regarded as an 
animal model of MS.  28–  30   Using intravital two-photon micros-
copy, Bartholomaus and others  28   showed that transferred 
myelin basic protein       reactive effector T cells first appear in 
the subarachnoid areas, where they crawl along the inner 
vascular surfaces of the pial blood vessels in the spinal cord 
and migrate through the vessel wall to enter the subarach-
noid space. Here, the T cells monitor the abluminal surface, 
and after an encounter with their specific antigen, presented 
by resident phagocytic cells in an major histocompatibility 
complex (MHC) II-restricted manner, they are restimulated 
and produce proinflammatory mediators that augment the 
inflammatory process including interferon (IFN)-γ and tumor 
necrosis factor (TNF)-α.  28   Previous studies using a murine 
model of CNS       human African trypanosomiasis (HAT) have 
shown significant increases in the levels of these two cytok-
ines in the brain compared with uninfected control mice at 
28 days post-infection.  18  Furthermore, rising CNS concentrations 
of IFN-γ and TNF-α were found to correlate with an increased 
severity in the neuroinflammatory reaction in these mice, and 
increased levels of IFN-γ have been detected in the plasma  31  and 
cerebrospinal fluid  32         of patients infected with   T. b. rhodesiense  
and  T. b. gambiense , respectively. The importance of IFN-γ in the 
passage of trypanosomes across the BBB has been suggested by 
studies using IFN-γ or IFN-γ receptor knockout mice, where 
transmigration of trypanosomes from the cerebral blood ves-
sels to the brain parenchyma was prevented. In addition, this 
impedance of parasite entry into the brain was also seen in 
recombination activating gene (RAG)-1 knockout mice, sug-
gesting that T and/or B cells play a role in the transmigratory 
process.  33  
  Several pathways have been shown to play important roles 
in the generation of the neuroinflammatory reaction. Studies 
employing substance P receptor antagonists in experimental 
trypanosome infections in mice have shown that this neuropep-
tide exerts a proinflammatory action in the brain of infected 
animals.  20,  34   Increased concentrations of this neuropeptide 
have also been detected in cerebral   Toxocara canis   infections 
in mice that, together with raised claudin-5 and neurokinin      -1 
receptor expression, were associated with persistent BBB 
impairment but little accompanying inflammation.  35   More 
recently, inhibition of kynurenine-3-monooxygenase (KMO), 
a key enzyme in the kynurenine pathway, reduced the severity 
of the CNS inflammation during the late CNS stage of the dis-
ease in an experimental murine model of HAT.  21   Furthermore, 
the kynurenine pathway metabolite quinolinic acid has been 
shown to increase the permeability of the BBB in rats to plasma 
albumin.  36   Therefore, if KMO inhibition produced a reduction 
in quinolinic acid, this could have helped to prevent the BBB 
impairment associated with the trypanosome infection. 
  The results gained from this investigation and the investiga-
tions of Philip and others  12   suggest that trypanosome infection 
reduces the integrity of the BBB.  12   The deleterious effects of 
this disease on the integrity of the BBB have also been sug-
gested by studies using   in situ   perfusion to monitor the ability 
of trypanocidal drugs to penetrate the CNS.  37,  38   In these stud-
ies, influx of both pentamidine and eflornithine into the brain 
parenchyma were minimal during the early stages of infec-
tion. However, the concentration of these drugs reaching the 
brain increased during the late stages of the disease, indicating 
a reduction in BBB function. These findings are in apparent 
contrast to those of Mulenga and others,  13   where no changes 
in the distribution of occludin or zona occludens (ZO)      -1 could 
be detected after trypanosome infection. However, it has been 
suggested that BBB leakiness in EAE is mainly because of 
opening of the tight junctions, with selective loss of claudin-3 
from vessels surrounded by inflammatory cells but no appar-
ent change in claudin-5, occludin, or ZO-1.  22   This could help 
to reconcile the apparently disparate results found between 
the investigation by Mulenga and others  13   and other contem-
porary studies examining the effects of trypanosome infection 
on the BBB. 
  We have now shown in this study that, using MRI meth-
odology, significant BBB dysfunction can be detected in mice 
exhibiting the early CNS stage of the disease when mild to 
moderate histopathological changes are apparent. However, 
further detailed studies using MRI will be required to delin-
eate and quantify the changes in BBB integrity throughout the 
course of trypanosome infection from the early acute stage of 
the disease, where no changes are detected on histopathologi-
cal examination, to the post-treatment reactive encephalopa-
thy      , where the animals exhibit a severe meningoencephalitis. 
Although these   in vivo   studies in experimental mice have cer-
tainly provided important insights into the neuropathogene-
sis of human African trypanosomiasis, there is now a pressing 349 MRI OF BBB DAMAGE IN T. BRUCEI INFECTION
need to use this type of neuroimaging technology wherever 
feasible in human patients with sleeping sickness. This will be 
important not only to improve our understanding of how the 
parasite gains access to the CNS to produce neurological dis-
ease but also to facilitate the development and in due course, 
assessment of new drug therapies. 
  Our findings in this model also have clear diagnostic impli-
cations for sleeping sickness in humans. According to the 
widely used World Health Organization criteria,  39   a CSF pleo-
cytosis of ≥ 5 white blood cells/μL is taken as a key diagnostic 
marker of late-stage disease, indicating that CNS involvement 
has occurred after BBB breakdown. However, our results 
reported here in mice suggest that such a close correlation 
between early BBB breakdown and brain involvement may 
not be as close or justified as generally thought. If so, then 
this further highlights the very difficult problem of diagnos-
tic markers for CNS trypanosomiasis, one that is particularly 
acute given the exceptional toxicity of current drug therapy 
for late-stage sleeping sickness.  2  
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